Solara Active Pharma Sciences Ltd

SOLARA

₹667.79

- ₹1.91

0.29%

Healthcare

₹0.00

(%)1D

Updated: 16 Sep 2025, 03:30:01 pm IST

Stock Score

Open Price

₹674.97

Prev. Close

₹669.70

₹655.81

Day Low

₹698.33

Day High

₹437.21

52 Week Low

₹870.07

52 Week High

Quick Bite

Price To Earnings Ratio 5136.85	Sector PE 68.46
PB Ratio 2.46	Sector PB 6.07
EPS 0.13	Dividend Yield 0.00
Today's Volume 133.385 K	5 Day Avg. Volume 86.795 K
PEG Ratio 51.32	Market Cap. ₹ 2,450.00 Cr.

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.

Solara Active Pharma Sciences Ltd Share Price

Solara Active Pharma Sciences Limited is an Indian company offering a wide range of commercial active ingredients (APIs) and contract manufacturing services in over 70 countries. The company operates through the API segment. Its commercial and R&D products include Albendazole, Aprepitant (Antiemetic), artesunate, brivaracetam (antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Sodium (Cinacalcet Hydrochloride). Anticonvulsants), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Anti-Tuberculosis Agent), Ethacrynic acid (Cardiovascular System Support Agent), Hydralazine Hydrochloride (Hypertensive Agent), Ibuprofen Sodium Dihydrate (Anti-Inflammatory Agent), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (treatment of OAB), pentoxifylline, etc. The company cooperates with North American, European and Japanese pharmaceutical companies.

Solara Active Pharma Sciences Ltd FAQs

How to Buy Solara Active Pharma Sciences Ltd Share?

To purchase Solara Active Pharma Sciences Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Solara Active Pharma Sciences Ltd (ticker symbol: SOLARA) on the trading platform provided by your broker and purchase the shares.

What's Solara Active Pharma Sciences Ltd share price today?

The stock price of Solara Active Pharma Sciences Ltd as of 17 Sep 2025 is ₹667.79

What is the Market Cap of Solara Active Pharma Sciences Ltd?

Market capitalisation represents the total market value of a company's outstanding shares. As of 17 Sep 2025, Solara Active Pharma Sciences Ltd (ticker symbol: SOLARA) has a market capitalisation of approximately ₹24,50,00,00,000.00

What is the PE and PB ratio of Solara Active Pharma Sciences Ltd?

Solara Active Pharma Sciences Ltd Ltd's price-to-book ratio as of 17 Sep 2025 is 2.46, reflecting the market's valuation compared to its asset value. As of 17 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 5136.85, indicating the market values the company at around ₹5,136.85 for every ₹1 of earnings

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd Share?

Solara Active Pharma Sciences Ltd Ltd (SOLARA) hit its 52-week high at ₹870.07, and its 52-week low at ₹437.21.

Begin your investment journey today

View All Global Indices